Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/1995
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/14/1995EP0656950A1 Tat-derived transport polypeptides
06/14/1995EP0656884A1 Novel poly-iodated compounds, method of preparation and contrast product containing same
06/14/1995EP0656762A1 Magnetic resonance arteriography with dynamic intravenous contrast agents
06/14/1995EP0484328B1 Process for the preparation of 2,4,6-triiodo-5-amino-isophthalamide compounds
06/14/1995EP0458841B1 Method for the use and synthesis of peptides
06/13/1995US5424419 Contrast medium for magnetic resonace imaging, exothermic medium for hyperthermia; very stable
06/13/1995US5424142 Gastrointestinal tract; improved images
06/13/1995US5424057 Medical diagnosis
06/13/1995US5424056 For diagnostic radiology of gastrointestinal tract
06/13/1995EP0724449A4 Preservative for pharmaceutical products
06/08/1995WO1995015341A1 Antibody against carcinoembryonic antigen (cea)
06/08/1995WO1995015335A2 Pretargeting methods and compounds
06/08/1995WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995WO1995015319A1 Paramagnetic chelates for nuclear magnetic resonance diagnosis
06/08/1995WO1995015307A1 Biphenyl iodinated derivatives and their diagnostic use
06/08/1995WO1995015306A1 Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals
06/08/1995WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
06/08/1995WO1995015153A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents
06/08/1995WO1995015118A1 Gas microspheres for topical and subcutaneous application
06/08/1995DE4341478A1 Antitumour compsn. comprising starch particles, cytostatic and contrast agent
06/08/1995CA2617836A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995CA2177991A1 A 46 kd human milk fat globule antigen
06/08/1995CA2177977A1 Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals
06/08/1995CA2177973A1 Process for enhancing the stability of liposomal suspensions containing hydrophilic active agents
06/08/1995CA2177962A1 Biphenyl iodinated derivatives and their diagnostic use
06/08/1995CA2177713A1 Gas microspheres for topical and subcutaneous application
06/08/1995CA2177584A1 Antibody against carcinoembryonic antigen (cea)
06/08/1995CA2177136A1 Pretargeting methods and compounds
06/07/1995EP0656368A1 Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide
06/07/1995EP0656121A1 Method for diagnosing and monitoring sepsis
06/07/1995EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates
06/07/1995EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/07/1995EP0655926A1 New tumor diagnosing or therapeutical probe
06/07/1995EP0454783B1 Site specific in-vivo activation of therapeutic drugs
06/06/1995US5422114 Compositions of iodoaniline derivatives and cellulose derivatives for visualization of the gastrointestinal tract
06/06/1995US5422096 Hydroxy-aryl metal chelates for diagnostic NMR imaging
06/06/1995US5422095 Low molecular weight polysaccharide complexes for radiation diagnosis
06/06/1995US5422094 19 F labelled antibodies and fragments thereof as NMR imaging and spectroscopy agents
06/06/1995CA1335819C Metal chelate containing diagnostic imaging contrast media
06/01/1995WO1995014934A1 Nmr chiral shift reagent comprising sugar derivative
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014726A1 Process for preparing polyazamacrocycles
06/01/1995WO1995014678A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production
06/01/1995WO1995014492A2 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
06/01/1995WO1995014491A2 Metal-ion chelates with acidic saccharides and glycosaminoglycans
06/01/1995CA2177470A1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivityand kinetic-spatial profiles
06/01/1995CA2177468A1 Metal-ion chelates with acidic saccharides and glycosaminoglycans
06/01/1995CA2177271A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2176595A1 Process for preparing polyazamacrocycles
05/1995
05/31/1995EP0655252A1 Agent for suppressing the motor activity of gastrointestinal tracts
05/31/1995EP0655247A1 Use of vincristine for the evaluation of substances at the neuroral level
05/31/1995EP0655055A1 Tachykinin antagonists
05/31/1995EP0654973A1 System of drug delivery to the lymphatic tissues
05/31/1995EP0640067A4 Improved synthesis of ioversol.
05/31/1995EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier
05/30/1995US5420176 Contrast media for ultrasonic imaging
05/30/1995US5419894 Complexing agents, complexes and complex salts
05/30/1995US5419893 Aminopolycarboxylic acids and derivatives thereof for magnetic resonance imaging
05/30/1995US5419892 Microfluidization of calcium/oxyanion-containing particles
05/30/1995CA1335720C Detection of necrotic malignant tissue and associated therapy
05/30/1995CA1335714C Fluorocarbon emulsions having saturated phospholipid emulsifiers
05/26/1995WO1995014039A1 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (lbp) and methods of their use
05/26/1995WO1995013834A1 Chimeric oligonucleoside compounds
05/26/1995WO1995013832A1 Immobilized labelling method
05/26/1995CA2176259A1 Chimeric oligonucleoside compounds
05/26/1995CA2175557A1 Immobilized labelling method
05/23/1995US5417960 Gadolinium complexes, magnetic resonance imaging
05/23/1995US5417959 Functionalized aza-crytand ligands for diagnostic imaging applications
05/23/1995US5417958 Heavy metal clusters for use as imaging agents
05/23/1995US5417213 Magnetic resonance arteriography with dynamic intravenous contrast agents
05/23/1995CA1335677C Ultrasonic manometry process in a fluid by means of micro bubbles
05/23/1995CA1335657C Three-dimensional cell and tissue culture system
05/18/1995WO1995013096A1 Labelled diagnostic compositions and methods of their use
05/18/1995WO1995013087A1 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
05/18/1995CA2176005A1 Labelled diagnostic compositions and methods of their use
05/17/1995EP0653063A1 In vitro test for dermal corrosive properties
05/17/1995EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals
05/17/1995EP0652885A1 Tetraazamacrocyclic metal complexes
05/17/1995EP0652777A1 Small animal metastasis model
05/17/1995EP0652746A1 Lymphatic delivery composition
05/17/1995EP0371992B1 Ionophores as reagents for detecting ions
05/16/1995US5416223 Iodinated esters
05/16/1995US5416016 Method for enhancing transmembrane transport of exogenous molecules
05/16/1995US5415867 High ratio active agent: lipid complex
05/16/1995CA1335565C Liposomes: efficient loading and controlled release of amphiphatic molecules
05/11/1995WO1995012818A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
05/11/1995WO1995012812A1 Method of monitoring patient compliance with medications prescriptions
05/11/1995WO1995012414A1 Novel modified pf4 compositions and methods of use
05/11/1995WO1995012386A1 Charged liposome preparation
05/11/1995CA2174326A1 Charged liposome preparation
05/11/1995CA2152954A1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
05/10/1995EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same
05/10/1995EP0496835B1 Solid tumor treatment method and composition
05/10/1995CN1102348A Water insoluble manganese particles as magnetic resonance contrast enhancement agents
05/09/1995US5414114 For magnetic resonance imaging
05/09/1995US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
05/04/1995WO1995011672A1 Detection of h. pylori in the stomach
05/04/1995CA2174933A1 Detection of h. pylori in the stomach